Your browser doesn't support javascript.
loading
FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation.
Keinicke, Helle; Sun, Gao; Mentzel, Caroline M Junker; Fredholm, Merete; John, Linu Mary; Andersen, Birgitte; Raun, Kirsten; Kjaergaard, Marina.
Affiliation
  • Keinicke H; Insulin and Device Trial Operations, Novo Nordisk A/S, Søborg, Denmark.
  • Sun G; Pharmacology and Histopathology, Novo Nordisk A/S, China.
  • Mentzel CMJ; Department of Experimental Animal Models, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark.
  • Fredholm M; Department of Veterinary Clinical and Animal Science, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark.
  • John LM; Global Obesity and Liver Disease Research, Novo Nordisk A/S, Måløv, Denmark.
  • Andersen B; Global Obesity and Liver Disease Research, Novo Nordisk A/S, Måløv, Denmark.
  • Raun K; Global Obesity and Liver Disease Research, Novo Nordisk A/S, Måløv, Denmark.
  • Kjaergaard M; Global Obesity and Liver Disease Research, Novo Nordisk A/S, Måløv, Denmark.
Endocr Connect ; 9(8): 755-768, 2020 Aug.
Article in En | MEDLINE | ID: mdl-32688339
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Endocr Connect Year: 2020 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Endocr Connect Year: 2020 Document type: Article